Latest Shareholder Equity News

WAM Leaders Limited has announced a fully franked ordinary dividend of 4.8 cents per share for the half-year ending December 2025, with a Dividend Reinvestment Plan available to shareholders.

Origin Energy has announced a fully franked dividend of AUD 0.30 per share for the six months ending December 2025, with a Dividend Reinvestment Plan available to shareholders.

Argenica Therapeutics has reported a significant increase in its half-year loss to $3.82 million, driven by reduced revenue and higher research and development expenses. The company continues to invest heavily in its neuroprotective drug candidate ARG-007 amid ongoing clinical trials.

BKI Investment Company Limited reported a 10% rise in net profit after tax for the half year ended December 2025, alongside a modest dividend increase and a strategic portfolio rotation favouring resources and energy transition themes.

Mesoblast Limited reported a 60% jump in Ryoncil sales to US$35 million for the December quarter, alongside securing a US$125 million credit facility that enhances its financial flexibility and supports ongoing clinical development.

Everest Metals Corporation has ramped up mining operations at its Mt Dimer Taipan Gold Project, delivering over 25,000 tonnes of ore and initiating a major drilling program to expand resources and optimise production.

Actinogen Medical has locked in a $4.3 million tranche of non-dilutive funding to support its pivotal Alzheimer’s disease trial, reinforcing its financial position as it nears critical interim and final results.

AMCIL Limited has announced a fully franked ordinary dividend of AUD 0.01 per share for the half-year ending December 2025, with options for dividend reinvestment and bonus securities.

29Metals has successfully closed its institutional entitlement offer, raising approximately $119 million at a notable discount, with a retail offer set to launch later this month. The capital raise aims to fuel key growth projects across its mining portfolio.

Algorae Pharmaceuticals has locked in a $3 million revolving debt facility with ScotPac, providing flexible, non-dilutive funding to accelerate its commercial operations across Australia and New Zealand.

Finder Energy has completed its acquisition of the Petrojarl I FPSO, issuing over 37 million shares to Amplus Energy as part of the US$15 million deal. Amplus’ Managing Director joins Finder’s board, signalling deeper collaboration.

Noble Helium has received a further unsecured loan of AUD 250,000 from its Executive Chair to support working capital, highlighting management’s confidence amid ongoing refinancing efforts.